You just read:

Eiger Completes Enrollment in Phase 2 LIMT HDV Study of Pegylated Interferon Lambda in Hepatitis Delta Virus Infection

News provided by

Eiger BioPharmaceuticals, Inc.

Jul 24, 2017, 08:00 ET